Citation: | LIU Shi-hua, ZHANG Chao, TIAN Zhi-gang, HOU Wen-zhe, ZHONG Ping. Expression and clinical significance of serum S-100β protein in patients with white matter ischaemic lesions[J]. Chinese Journal of General Practice, 2021, 19(1): 38-41. doi: 10.16766/j.cnki.issn.1674-4152.001724 |
[1] |
PANTONI L, FIERINI F, POGGESI A. Impact of cerebral white matter changes on functionality in older adults: An overview of the LADIS Study results and future directions[J]. Geriatr Gerontol Int, 2015, 15(Suppl 1): 10-16. doi: 10.1111/ggi.12665/pdf
|
[2] |
CHUTINET A, ROST N S. White matter disease as a biomarker for long-term cerebrovascu WMILr disease and dementia[J]. Curr Treat Options Cardiovasc Med, 2014, 16(3): 292. doi: 10.1007/s11936-013-0292-z
|
[3] |
DOIT, SHIMADA H, MAKIZAKO H, et al. Effects of white matter lesions on trunk stability during dual-task walking among older adults with mild cognitive impairment[J]. Age (Dordr), 2015, 37(6): 120. doi: 10.1007/s11357-015-9858-x
|
[4] |
RYU W S, WOO S H, SCHELLINGERHOUT D, et al. Stroke outcomes are worse with larger leukoaraiosis volumes[J]. Brain, 2017, 140(1): 158-170. doi: 10.1093/brain/aww259
|
[5] |
CRISTÓVÀO J S, MORRIS V K, CARDOSO I, et al. The neuronal S-100β protein is a calcium-tuned suppressor of amyloid-β aggregation[J]. Sci Adv, 2018, 4(6): 1702. doi: 10.1126/sciadv.aaq1702
|
[6] |
QIN B, PANICKAR K S, ANDERSON R A, et al. Cinnamon polyphenols attenuate the hydrogen peroxide-induced down regulation of S-100 beta secretion by regulating sirtuin 1 in C6 rat glioma cells[J]. Life Sci, 2014, 102(1): 72-79. doi: 10.1016/j.lfs.2014.02.038
|
[7] |
LIU W, HUO X, LIU D, et al. S-100βprotein in heavy metal-related child attention-deficit hyperactivity disorder in an informal e-waste recycling area[J]. Neurotoxicology, 2014, 45: 185-191. doi: 10.1016/j.neuro.2014.10.013
|
[8] |
GILSTON B A, SKAAR E P, CHAZIN W J, et al. Binding of transition metals to S-100 proteins[J]. Sci China Life Sci, 2016, 59(8): 792-801. doi: 10.1007/s11427-016-5088-4
|
[9] |
WANG F, ZOU Z R, YUAN D, et al. Correlation between serum S100β protein levels and cognitive dysfunction in patients with cerebral small vessel disease: a case-control study[J]. Biosci Rep, 2017, 37(2): BSR20160446. doi: 10.1042/BSR20160446
|
[10] |
ERCOLE A, THELIN E P, HOLST A, et al. Kinetic modelling of serum S100b after traumatic brain injury[J]. BMC Neurol, 2016, 16: 93. doi: 10.1186/s12883-016-0614-3
|
[11] |
KOH S X, LEE J K. S100B as a marker for brain damage and blood-brain barrier disruption following exercise[J]. Sports Med, 2014, 44(3): 369-385. doi: 10.1007/s40279-013-0119-9
|
[12] |
BRESNICK A R. S100 proteins as therapeutic targets[J]. Biophys Rev, 2018, 10(6): 1617-1629. doi: 10.1007/s12551-018-0471-y
|
[13] |
LI K, JIA J, WANG Z, et al. Elevated Serum Levels of NSE and S-100β correlate with increased risk of acute cerebral infarction in Asian populations[J]. Med Sci Monit, 2015, 21: 1879-1888. doi: 10.12659/MSM.893615
|
[14] |
DIMOPOULOS C, DAMASKOS C, PAPADAKIS M, et al. Expression of S-100βprotein in ischemia/reperfusion-induced brain injury after cyclosporine therapy: a biochemical serum marker with prognostic value?[J]. Med Sci Monit, 2019, 25: 1637-1644. doi: 10.12659/MSM.912810
|
[15] |
ERCOLE A, THELIN E P, HOLST A, et al. Kinetic modelling of serum S-100βafter traumatic brain injury[J]. BMC Neurol, 2016, 16: 93. doi: 10.1186/s12883-016-0614-3
|
[16] |
LU Y L, WANG R, HUANG H T, et al. Association of S100B polymorphisms and serum S100B with risk of ischemic stroke in a Chinese population[J]. Sci Rep, 2018, 8(1): 971. doi: 10.1038/s41598-018-19156-w
|
[17] |
KANAVAKI A, SPENGOS K, MORAKI M, et al. Serum Levels of S100β and NSE proteins in patients with non-transfusion-dependent thalassemia as biomarkers of brain ischemia and cerebral vasculopathy[J]. Int J Mol Sci, 2017, 18(12): 2724. doi: 10.3390/ijms18122724
|
[18] |
RENSMA S P, VAN SLOTEN T T, LAUNER L J, et al. Cerebral small vessel disease and risk of incident stroke, dementia and depression, and all-cause mortality: a systematic review and meta-analysis[J]. Neurosci Biobehav Rev, 2018, 90: 164-173. doi: 10.1016/j.neubiorev.2018.04.003
|
[19] |
BLAIR G W, HERNANDEZ M V, THRIPPLETON M J, et al. Advanced neuroimaging of cerebral small vessel disease[J]. Curr Treat Options Cardiovasc Med, 2017, 19(7): 56. doi: 10.1007/s11936-017-0555-1
|
[20] |
黄瑞, 曹红. 缺血性脑白质疏松症病变部位危险因素分析[J]. 中国现代神经疾病杂志, 2018, 18(11): 830-836. doi: 10.3969/j.issn.1672-6731.2018.11.013
|
[21] |
王晓霞, 徐燕. 原发性高血压患者24 h动态血压变异性与脑白质病变的相关性研究[J]. 中国实用医刊, 2019, 46(7): 89-91. https://www.cnki.com.cn/Article/CJFDTOTAL-LNXG201909006.htm
|
[22] |
方立, 袁学谦, 张莉峰, 等. 血压变异干预策略对高血压脑白质疏松、预后卒中及认知的影响[J]. 中国现代医学杂志, 2019, 29(13): 103-108. https://www.cnki.com.cn/Article/CJFDTOTAL-ZXDY201913020.htm
|
[23] |
李复兴, 王荔. 脑白质病变与糖化血红蛋白及糖尿病年限的相关性研究[J]. 临床医药实践, 2015, 24(9): 695-698. https://www.cnki.com.cn/Article/CJFDTOTAL-SXLC201509021.htm
|
[24] |
罗彦妮, 覃冬华, 钟良, 等. 缺血性脑白质病变患者发生认知功能障碍的影响因素分析[J]. 广西医学, 2018, 40(12): 1299-1301. https://www.cnki.com.cn/Article/CJFDTOTAL-GYYX201812009.htm
|